Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Diamedica Therapeutics Inc (DMAC)

95 + Investors. Track Smart Money conviction in DMAC. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +5
Streak
3Q ▲
Buyers last Q
55%

Smart Money Signals — DMAC

Based on 96 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added DMAC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
96 hedge funds hold DMAC right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +66% more funds vs a year ago

fund count last 6Q
+38 new funds entered over the past year (+66% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 55% buying

47 buying39 selling
Last quarter: 47 funds bought or added vs 39 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~19 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 21 → 26 → 22 → 19. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 30% long-term, 42% new

■ 30% conviction (2yr+) ■ 28% medium ■ 42% new
Of the 96 current holders: 29 (30%) held >2 years, 27 held 1–2 years, and 40 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
➡️

Steady discovery — ~19 new funds/quarter

15 → 21 → 26 → 22 → 19 new funds/Q
New funds entering each quarter: 21 → 26 → 22 → 19. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 43% veterans vs 48% newcomers

■ 43% veterans ■ 8% 1-2yr ■ 48% new
Entry-cohort mix of 99 holders: 43 (43%) are 2+ year veterans, 8 entered 1–2 years ago, and 48 (48%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 32% AUM from major funds

32% from top-100 AUM funds
29 of 96 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.9
out of 10
Moderate Exit Risk
Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DMAC

In 2026 Q1, 47 hedge funds were net buyers of DMAC (19 opened a new position, 28 added to an existing one), while 39 reduced or exited (25 trimmed, 14 sold completely) — a 55% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 32% of total institutional value in DMAC is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +5 funds (more new holders than closures). Total institutional holders: 96.

Hedge Fund Ownership: DMAC

How many hedge funds hold DMAC — quarterly history vs. share price
Quarterly hedge fund ownership of DMAC vs. share price

Market Analysis: DMAC

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DMAC

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Diamedica Therapeutics Inc (DMAC) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much DMAC has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 92d ago
DMAC
+4.0%
XLV
+10.1%

DMAC outperformed XLV by -6.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 47d ago
DMAC
+16.2%
XLV
+11.3%

Since the filing became public, DMAC outperformed XLV by +4.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 1 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
1.3
/ 10
conviction
Hedge Fund Positioning: DMAC
95 + Investors

Track Smart Money conviction in DMAC. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 95 91 4.4%
13F Shares 12M 12M -3.25%
Total Value $79M $96M -18.21%
New Positions 18 22 -4
Increased Positions 27 34 -7
Closed Positions 14 9 +5
Reduced Positions 24 19 +5
Total Calls 2 1 100.0%
Total Puts 1 2 -50.0%
PUT/CALL Ratio 0.5 2.0 Bullish

Statistics: DMAC

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

95 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DMAC. Verified SEC 13F-HR filings.

QUARTER:
Top 25 DMAC holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Paragon Associates & Paragon Associates II Joint Venture 8.05% 875,000 $5.9M
2 Cooperman Leon G 0.45% 2,020,000 $13.7M
3 Bleichroeder LP 0.45% 382,317 $2.6M
4 Members Wealth LLC 0.39% 101,382 $656K
5 Corient IA LLC 0.38% 60,000 $406K
6 Kalehua Capital Management LLC 0.36% 62,488 $423K
7 Magnolia Capital Advisors LLC 0.10% 77,405 $524K
8 Informed Momentum Co LLC 0.07% 91,425 $619K
9 Private Capital Management, LLC 0.03% 50,000 $338K
10 Catalyst Financial Partners LLC 0.03% 38,457 $260K
11 AWM Investment Company, Inc. 0.03% 36,000 $244K
12 Truvestments Capital LLC 0.01% 9,849 $67K
13 Meridian Wealth Management, LLC 0.01% 48,641 $329K
14 First Manhattan CO. LLC. 0.01% 455,000 $3.1M
15 Stonebridge Capital Advisors LLC 0.01% 17,500 $118K
16 Capital & Planning, LLC 0.01% 2,001 $14K
17 Cornerstone Wealth Management, LLC 0.01% 16,250 $110K
18 Blue Trust, Inc. 0.01% 69,122 $468K
19 World Investment Advisors 0.00% 36,975 $250K
20 ExodusPoint Capital Management, LP 0.00% 60,011 $406K
21 Osaic Holdings, INC. 0.00% 319,675 $2.2M
22 Millennium Management LLC 0.00% 935,592 $6.3M
23 China Universal Asset Management Co., Ltd. 0.00% 5,000 $34K
24 Quadrature Capital Ltd 0.00% 22,039 $149K
25 Perigon Wealth Management, LLC 0.00% 13,957 $94K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Diamedica Therapeutics Inc (DMAC)

What does the Smart Money Trend signal show for DMAC?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added DMAC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for DMAC?

Slight buying edge — 55% buying: Last quarter: 47 funds bought or added vs 39 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for DMAC holders?

Strong quality — 32% AUM from major funds: 29 of 96 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held DMAC?

Mixed — 30% long-term, 42% new: Of the 96 current holders: 29 (30%) held >2 years, 27 held 1–2 years, and 40 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Diamedica Therapeutics Inc (DMAC) following the 2026 Q1 hedge fund 13F filings?

As of today, DMAC has moved +16.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +11.3% for the XLV sector ETF — an outperformance of +4.9%. Since the quarter end (March 31, 2026), DMAC has gained +4.0% vs +10.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →